Major autism breakthrough could revolutionise treatments and care
Scientists at Princeton University and the Simons Foundation analysed data from 5,000 children in SPARK, an autism cohort study, to group individuals based on their combination of traits.
Instead of searching for genetic links to certain traits, researchers considered a range of over 230 traits in each individual, from social interactions to repetitive behaviours to developmental milestones.
From this analysis, they were able to identify four subtypes of autism with different patterns of genetic variation.
'What we're seeing is not just one biological story of autism, but multiple distinct narratives," said Natalie Sauerwald, associate research scientist at the Flatiron Institute and co-lead author.
'This helps explain why past genetic studies often fell short—it was like trying to solve a jigsaw puzzle without realizing we were actually looking at multiple different puzzles mixed together. We couldn't see the full picture, the genetic patterns, until we first separated individuals into subtypes.'
The four subtypes were Social and Behavioral Challenges, Mixed ASD with Developmental Delay, Moderate Challenges, and Broadly Affected.
The first type relates to children reaching developmental milestones at a similar pace to children without autism, but they often experience co-occurring conditions like ADHD, anxiety or depression.
The second type showed a delay in reaching developmental milestones but with no signs of co-occurring conditions.
The third type, Moderate Challenges, shows core autism-related behaviours but less strongly than other groups, reaching milestones at a similar pace to children without autism and with no co-occurring conditions.
The fourth type faces the most extreme and wide-ranging challenges.
The first and third types were the most common, with 37 per cent and 34 per cent of participants found to be in each group, respectively, while the second and fourth types were the least common, with 19 per cent and 10 per cent of participants in each group.
The findings highlight how genetic differences 'suggest distinct mechanisms behind superficially similar clinical presentations'.
For example, children in both the Broadly Affected and Mixed ASD groups share some important traits, such as developmental delay and intellectual disability, but the former group showed the highest proportion of de novo mutations, which are not inherited from either parent, whereas the latter group was more likely to carry rare inherited genetic variants.
The findings do not mean there are only four subtypes of autism; they establish the discovery of a data-driven framework showing there are at least four, and that they are meaningful both for clinical work and research at the genome level.
For families navigating autism, knowing which subtype of autism their child has can offer new clarity, tailored care, support and community.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
26 minutes ago
- The Independent
PEPFAR keeps millions of people with HIV alive and may be spared from Trump spending cuts
The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government says it has saved the lives of over 25 million people around the world with HIV. But despite years of bipartisan support, PEPFAR has faced a severe threat as the Trump administration dismantles most U.S. foreign aid. PEPFAR on Tuesday appeared to be spared a $400 million cut as Republicans acted in rare defiance of a request by President Donald Trump. But governments, health experts and people with HIV around the world are alarmed by the effects of other U.S. aid cuts and chaos that are already disrupting the crucial supply of HIV drugs — which are meant to be taken daily. Here's a look at PEPFAR and how it affects millions of people globally. Fears of an AIDS resurgence Today, many babies are born infection-free to mothers with HIV — the U.S. State Department says PEPFAR has been responsible for 5.5 million such births — and most people around the world no longer see an infection as a death sentence. Governments in Africa and elsewhere had even begun to worry about complacency as people, especially youths, took the widespread availability of HIV drugs for granted. In another significant step forward, the U.S. Food and Drug Administration recently approved for use the world's only twice-a-year shot to prevent HIV. But the abrupt U.S. aid cuts have health officials in developing countries warning of a return to the early days of the AIDS pandemic, when drugs were nonexistent or severely limited and clinics were filled with the dying. PEPFAR was launched in 2004 in response to those grim scenes. Also known as the U.S. President's Emergency Plan for AIDS Relief, the program has partnered with nonprofit groups to provide HIV medication — including the preventative PrEP — to millions around the world. It has strengthened national health care systems, cared for children orphaned by AIDS and provided job training for people at risk. It has played an important role in testing for and tracking HIV infections. HIV/AIDS has no cure, and it has killed over 40 million people globally over the years. Now the U.N. agency on AIDS is warning that analysis suggests 4 million additional AIDS-related deaths between now and 2029, including 300,000 additional children's deaths, if programs permanently lose PEPFAR's support. From widespread support to baseless claims Since PEPFAR's creation by Congress and Republican President George W. Bush, the program has largely enjoyed support across the political spectrum — and gratitude from countries whose health systems have been poorly equipped to care for millions with HIV. But misinformation has crept in. The Heritage Foundation, an influential conservative Washington think tank, accused the Biden administration of using PEPFAR 'to promote its domestic radical social agenda overseas.' Conservatives claimed there were efforts to integrate abortion with HIV/AIDS prevention, a claim the Biden administration denied. Similar claims linger under the Trump administration. Trump and his officials also claim widespread waste and fraud as they seek to dismantle U.S. foreign aid. But PEPFAR has been repeatedly scrutinized. Last year, the government said the State Department's Office of Inspector General had conducted 80 audits, inspections, and special reviews that included oversight of PEPFAR programs, 'including 21 thematic reviews and audits specifically focused on PEPFAR.' Impossible to replace US funding The $400 million proposed cut to PEPFAR still could be restored, in part or in full, as the bill on spending cuts faces a final vote in the Senate, a vote in the House of Representatives and Trump's signature before a Friday deadline. 'We must stay vigilant,' International AIDS Society President Beatriz Grinsztejn said in a statement Wednesday after PEPFAR appeared to be spared. No matter what, countries and health experts say it will be impossible to fill the funding gap left by the overall U.S. withdrawal of billions of dollars in aid for the global HIV response, including via PEPFAR. Last month, a UNAIDS report said the abrupt cuts have 'destabilized supply chains, led to the closure of health facilities, left thousands of health clinics without staff, set back prevention programs, disrupted HIV testing efforts and forced many community organizations to reduce or halt their HIV activities.' South Africa, where more people live with HIV than anywhere else in the world, has said 12 specialized HIV clinics that were funded by the U.S. have had to close down and over 8,000 health workers in its national HIV program are out of work. Now health workers there and elsewhere are trying to track down an unknown number of people who have lost access to HIV medication. The stakes are deadly. Stopping the drugs allows the virus to start multiplying again. HIV can rebound to detectable levels in people's blood in just a few weeks, putting sexual partners at risk. The virus could even become drug-resistant. 'It has really been hectic for us,' said Mbonisiwe Hlongwane, manager of the HIV program at the Bertha Gxowa public hospital in Germiston, east of Johannesburg. And the uncertainty only continues. ___
Reuters
27 minutes ago
- Reuters
Texas probes M&M maker Mars' resistance to removing synthetic dyes
July 16 (Reuters) - Texas' attorney general said on Wednesday he has begun investigating Mars, which makes M&M's and Skittles candies, for its alleged refusal to remove synthetic food dyes from its products. Ken Paxton, the attorney general, said in a statement that he issued a civil investigative demand for documents from Mars, as he examines whether the family-owned company violated consumers' rights through deceptive trade practices. Paxton said Mars has not fulfilled its 2016 pledge, opens new tab to remove all artificial colors from food products, saying it had removed "toxic" dyes in Europe but not the United States. "It's time for Mars to follow the lead of other companies like Nestle and Hershey by removing synthetic dyes from its products," Paxton said. "It's the right thing to do." Mars, based in McLean, Virginia, had no immediate comment. Removing synthetic food dyes and reducing Americans' consumption of ultraprocessed foods has been a priority for U.S. Health and Human Services Secretary Robert F. Kennedy Jr, as part of his "Make America Healthy Again" campaign. Kennedy has blamed the dyes for health problems including attention deficit hyperactivity disorder and cancer, though many scientists say more research is needed. General Mills (GIS.N), opens new tab, J.M. Smucker (SJM.N), opens new tab, Kraft Heinz (KHC.O), opens new tab and PepsiCo (PEP.O), opens new tab, as well as Hershey (HSY.N), opens new tab and Nestle (NESN.S), opens new tab, are among companies that have committed to removing the dyes by 2028 or earlier. Mars has said its consumers have different attitudes toward artificial colors in food depending on where they live, with European consumers preferring the dyes removed while other consumers prefer to keep them.
Daily Mail
an hour ago
- Daily Mail
I'm 25 and I have cancer that kills more than half of those who get it...there are two symptoms doctors dismissed
At just 25 years old, Savannah Caldwell had her whole life ahead of her. The Kentucky native was healthy, active, and cherished time with her friends and the four stepchildren she helped raise. But when she began experiencing persistent exhaustion and aching bones, she turned to doctors for answers. Physicians initially denied her tests saying she was 'too young for cancer', but after a lump was found on her chest they hey agreed to run further tests, and a biopsy was performed. Days later, she was diagnosed with stage four breast cancer that had spread to her ribs, spine, lungs, and possibly her skull. Doctors gave her just a 32 percent chance of surviving the next five years. She said: 'I was in complete shock. I remember staring at the floor not knowing what to think, not knowing what was next, that was a big worry. 'I've had to grow up faster in a week than I have in 25 years.' Caldwell is just one of the ever-increasing number of women diagnosed with breast cancer before they turn 50, which is now among the fastest growing cancers in the age group alongside colon cancer. rising by up to 1.85 percent per year, with an extra 4,000 women being diagnosed with the cancer annually in the US compared to a decade ago. While breast cancer in women in their 20s is rare, it's not unheard of. About 6.5 out of every 100,000 women in their 20s will receive a breast cancer diagnosis, according to the American Cancer Society They remain puzzled by the surge, especially in healthy, young individuals, though some have pointed to possible environmental triggers or earlier onset of puberty as potential factors. For Caldwell, who is from Russell,the diagnosis came with devastating physical symptoms. Shortly after learning she had stage four breast cancer, the 25-year-old developed crippling back pain caused by a tumor pressing against her spine. The pain became so severe it made walking and even basic movement difficult. Doctors immediately began an aggressive treatment plan, starting with 12 rounds of chemotherapy. Caldwell has already completed nine and may also undergo immunotherapy and radiation depending on how her body responds. Revealing her story to local news station WSAZ, she said: 'At night, especially when with my kids, whenever we cuddle up... I look over... and I just hope I get to see them grow up. 'Things change minute-by-minute, but for the most part I am being very optimistic. I hope my will to fight can get me through. 'I want to fight, I want to live and I want my story to be a beautiful one no matter how long or short it is.' Caldwell said the chemotherapy has gone well so far, but that she has started to lose her hair and has been losing weight rapidly, now being down to 88lbs. In an update after her fourth round of chemotherapy in June, she said: 'Between the third and fourth chemo a lot has changed. 'My hair is thinning a lot, just yesterday I noticed it is coming out in clumps. I am still experiencing a lot of back pain, neck pain, [pain] in my ribs. 'Through the night, I wake up very nauseous and almost projectile vomiting and it is harder to eat.' She added: 'I look forward to getting this over with, and getting through.' After the ninth chemotherapy, she said she was 'still not sleeping much' but 'hanging in there'. Doctors have diagnosed her with invasive ductal carcinoma, the most common form of breast cancer and behind about 80 percent of all cases. Her friends have started a fundraiser online to raise money to help cover bills and complications linked to the chemotherapy. On the page, they write: 'Savannah is not going to be able to work for a long time. Please help her fight this beast. 'She'd give the shirt off her back for any stranger she met. Let's come together and help her and her fiance!' Research published earlier this year that analyzed 2.1million cases of early-onset cancer diagnosed between 2010 and 2019 found breast cancer, thyroid cancer and melanoma were the fastest rising among young women. Among young men, colon cancer, testicular cancer and melanoma were the most likely to be diagnosed before someone turned 50 years old. Doctors have also suggested that a trend toward having a first child at a later age could be a possible explanation for the rise in diagnoses.
